Clinical Significance Of Oral Dosage Form Of Alpha1-blockers With Modified Release In Management Of Patients With Benign Prostatic Hypertrophy
The author review the characteristics of pharmacokinetics, clinical efficacy and tolerability of oral dosage forms of alpha1-blockers with modified release, used in the treatment of lower urinary tract symptoms in patients with benign prostatic hypertrophy. The following dosage forms are considered: doxazosin GITS, alfuzosin with slow release (Dalfaz retard) and controlled release (Dalfaz CR), tamsulosin with modified release (Omnic) and controlled release (Omnic Okas).M.Leonova С. 3642
Keywords
benign prostatic hypertrophy
lower urinary tract symptoms
hypertension
doxazosin
alfuzosin
tamsulosin
Similar Articles
